These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Relationship between occurrence of surgical complications and hospital finances. Eappen S; Lane BH; Rosenberg B; Lipsitz SA; Sadoff D; Matheson D; Berry WR; Lester M; Gawande AA JAMA; 2013 Apr; 309(15):1599-606. PubMed ID: 23592104 [TBL] [Abstract][Full Text] [Related]
23. Estimating revenue, costs, and operating margin of any hospital-based thoracic surgery practice using a novel financial model. Ashrafi A; Atay SM; Wightman SC; Harano T; Kim AW J Thorac Cardiovasc Surg; 2023 Sep; 166(3):690-698.e1. PubMed ID: 36934070 [TBL] [Abstract][Full Text] [Related]
24. The Effect of Payer Type on Patient-Reported Outcomes in Total Joint Arthroplasty Is Modulated by Baseline Patient Characteristics. Halawi MJ; Cote MP; Savoy L; Williams VJ; Lieberman JR J Arthroplasty; 2019 Jun; 34(6):1072-1075. PubMed ID: 30797645 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the hospital cost of primary and revision total hip arthroplasty after cost containment. Iorio R; Healy WL; Richards JA Orthopedics; 1999 Feb; 22(2):185-9. PubMed ID: 10037332 [TBL] [Abstract][Full Text] [Related]
26. What Financial Incentives Will Be Created by Medicare Bundled Payments for Total Hip Arthroplasty? Clement RC; Kheir MM; Soo AE; Derman PB; Levin LS; Fleisher LA J Arthroplasty; 2016 Sep; 31(9):1885-9. PubMed ID: 27067173 [TBL] [Abstract][Full Text] [Related]
27. Financial viability of endovascular aortic repair in the modern era. Brinster CJ; Escousse GT; Bazan HA; Leithead CC; Sternbergh WC J Vasc Surg; 2021 Feb; 73(2):494-501. PubMed ID: 32473346 [TBL] [Abstract][Full Text] [Related]
28. The Financial Burden of Patient Comorbidities on Total Hip Arthroplasties-A Matched Cohort Analysis of High Comorbidity Burden and Non-High Comorbidity Burden Patients. Ashkenazi I; Thomas J; Katzman J; Meftah M; Davidovitch R; Schwarzkopf R J Arthroplasty; 2024 Sep; 39(9S1):S29-S33. PubMed ID: 38417554 [TBL] [Abstract][Full Text] [Related]
29. An Analysis of Centers for Medicare & Medicaid Service Payment in Maryland: Can a Global Budget Revenue Model Save Money in Lower Extremity Arthroplasty? Delanois RE; Gwam CU; Cherian JJ; Etcheson JI; Dávila Castrodad IM; Spindler KP; Mont MA J Arthroplasty; 2019 Feb; 34(2):201-205. PubMed ID: 30389256 [TBL] [Abstract][Full Text] [Related]
30. The Financial Feasibility of Bilateral Total Knee Arthroplasty: A Matched Cohort Analyses of Revenue and Contribution Margin Between Simultaneous and Staged Procedures. Ashkenazi I; Rajahraman V; Lawrence KW; Lajam CM; Bosco JA; Schwarzkopf R J Arthroplasty; 2024 Jul; 39(7):1645-1649. PubMed ID: 38242509 [TBL] [Abstract][Full Text] [Related]
31. The Effects of Revision Total Hip Arthroplasty on Medicare Spending and Beneficiary Outcomes: Implications for the Comprehensive Care for Joint Replacement Model. Koenig L; Feng C; He F; Nguyen JT J Arthroplasty; 2018 Sep; 33(9):2764-2769.e2. PubMed ID: 29914819 [TBL] [Abstract][Full Text] [Related]
32. Medicaid insurance as primary payer predicts increased mortality after total hip replacement in the state inpatient databases of California, Florida and New York. Xu HF; White RS; Sastow DL; Andreae MH; Gaber-Baylis LK; Turnbull ZA J Clin Anesth; 2017 Dec; 43():24-32. PubMed ID: 28972923 [TBL] [Abstract][Full Text] [Related]
33. Registry Data Show Complication Rates and Cost in Revision Hip Arthroplasty. Duwelius PJ; Southgate RD; Crutcher JP; Rollier GM; Li HF; Sypher KS; Tompkins GS J Arthroplasty; 2023 Jul; 38(7S):S29-S33. PubMed ID: 37121489 [TBL] [Abstract][Full Text] [Related]
34. How Much Does a Readmission Cost the Bundle Following Primary Hip and Knee Arthroplasty? Phillips JLH; Rondon AJ; Vannello C; Fillingham YA; Austin MS; Courtney PM J Arthroplasty; 2019 May; 34(5):819-823. PubMed ID: 30755375 [TBL] [Abstract][Full Text] [Related]
35. Medicaid Payer Status Is Associated With Increased 90-Day Resource Utilization, Reoperation, and Infection Following Aseptic Revision Total Hip Arthroplasty. Sharma A; Farley KX; Schwartz AM; Wilson JM; Bradbury TL; Guild GN Iowa Orthop J; 2022; 42(2):66-74. PubMed ID: 36601230 [TBL] [Abstract][Full Text] [Related]
36. The Affordable Care Act and Global Budget Revenue: The Impact on Total Hip Arthroplasties. Delanois RE; Wilkie WA; Mohamed NS; Remily EA; Pollak AN; Mont MA J Arthroplasty; 2020 Oct; 35(10):2791-2797. PubMed ID: 32561265 [TBL] [Abstract][Full Text] [Related]
38. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty? Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823 [TBL] [Abstract][Full Text] [Related]
39. Impact of Co-Morbidities on the Cost of Care in Primary Elective Joint Arthroplasty. Penna S; Bell KL; Kuo FC; Henderson RA; Foltz C; Chen AF J Arthroplasty; 2019 May; 34(5):834-838. PubMed ID: 30777622 [TBL] [Abstract][Full Text] [Related]
40. Cost burden of 30-day readmissions following Medicare total hip and knee arthroplasty. Bosco JA; Karkenny AJ; Hutzler LH; Slover JD; Iorio R J Arthroplasty; 2014 May; 29(5):903-5. PubMed ID: 24332969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]